A detailed history of Adar1 Capital Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 200 shares of NVO stock, worth $22,390. This represents 0.01% of its overall portfolio holdings.

Number of Shares
200
Previous 100 100.0%
Holding current value
$22,390
Previous $12.8 Million 122.34%
% of portfolio
0.01%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$122.71 - $146.91 $12,271 - $14,691
100 Added 100.0%
200 $28.5 Million
Q1 2024

May 15, 2024

SELL
$102.11 - $135.92 $638,187 - $849,499
-6,250 Reduced 98.43%
100 $12.8 Million
Q4 2023

Feb 14, 2024

BUY
$87.78 - $105.45 $557,403 - $669,607
6,350 New
6,350 $657 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $253B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Adar1 Capital Management, LLC Portfolio

Follow Adar1 Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adar1 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adar1 Capital Management, LLC with notifications on news.